00-17700. Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP): Cooperative Agreements to Develop Core State-Based Surveillance Model Programs, RFA OH-00-007, and Development of New or Enhanced Models for State-Based ...  

  • Start Preamble

    In accordance with section 10(a)(2) of the Federal Advisory Committee Act (Pub. L. 92-463), the Centers for Disease Control and Prevention (CDC) announces the following meeting.

    Name: Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP): Cooperative Agreements to Develop Core State-Based Surveillance Start Printed Page 43377Model Programs, RFA OH-00-007, and Development of New or Enhanced Models for State-Based Occupational Surveillance, RFA OH-00-008.

    Times and Dates: 8 a.m.-8:30 a.m., August 2, 2000 (Open).

    8:30 a.m.-5 p.m., August 2, 2000 (Closed).

    8 a.m.-5 p.m., August 3, 2000 (Closed).

    Place: Embassy Suites, 1900 Diagonal Road, Alexandria, Virginia 22314.

    Status: Portions of the meeting will be closed to the public in accordance with provisions set forth in section 552b(c)(4) and (6), Title 5 U.S.C., and the Determination of the Associate Director for Management and Operations, CDC, pursuant to Public Law 92-463.

    Matters to be Discussed: The meeting will include the review, discussion, and evaluation of applications received in response to RFA-OH-00-007 and RFA OH-00-008.

    Contact Person for More Information: Michael J. Galvin, Jr., Ph.D., Health Science Administrator, Centers for Disease Control and Prevention, National Institute for Occupational Safety and Health, 1600 Clifton Road, N.E., m/s D30 Atlanta, Georgia 30333. Telephone 404/639-3525, e-mail mtg3@cdc.gov.

    The Director, Management Analysis and Services office has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities, for both the Centers for Disease Control and Prevention and the Agency for Toxic Substances and Disease Registry.

    Start Signature

    Dated: July 7, 2000.

    Julia M. Fuller,

    Acting Director, Management Analysis and Services Office, Centers for Disease Control and Prevention CDC.

    End Signature End Preamble

    [FR Doc. 00-17700 Filed 7-12-00; 8:45 am]

    BILLING CODE 4163-19-P

Document Information

Published:
07/13/2000
Department:
Centers for Disease Control and Prevention
Entry Type:
Notice
Document Number:
00-17700
Dates:
8 a.m.-8:30 a.m., August 2, 2000 (Open).
Pages:
43376-43377 (2 pages)
PDF File:
00-17700.pdf